{"identifier":"/us/usc/t42/s280g","title_num":"42","num":"§ 280g.","heading":"Children’s asthma treatment grants program","status":null,"guid":"id5ebcd6ec-4aa7-11eb-94f5-9ff2c44f6f3c","source_credit":"(July 1, 1944, ch. 373, title III, § 399L, as added Pub. L. 106–310, div. A, title V, § 501, Oct. 17, 2000, 114 Stat. 1113; amended Pub. L. 108–377, § 3(a), Oct. 30, 2004, 118 Stat. 2203; Pub. L. 113–48, § 2, Nov. 13, 2013, 127 Stat. 575; Pub. L. 114–95, title IX, § 9215(kkk)(2), Dec. 10, 2015, 129 Stat. 2187.)","seq_in_title":385,"parent_identifier":"/us/usc/t42/ch6A/schII/ptP","ancestors":[{"identifier":"/us/usc/t42","level":"title","num":"Title 42—","heading":"THE PUBLIC HEALTH AND WELFARE","status":null,"is_section":false},{"identifier":"/us/usc/t42/ch6A","level":"chapter","num":"CHAPTER 6A—","heading":"PUBLIC HEALTH SERVICE","status":null,"is_section":false},{"identifier":"/us/usc/t42/ch6A/schII","level":"subchapter","num":"SUBCHAPTER II—","heading":"GENERAL POWERS AND DUTIES","status":null,"is_section":false},{"identifier":"/us/usc/t42/ch6A/schII/ptP","level":"part","num":"Part P—","heading":"Additional Programs","status":null,"is_section":false}],"xml":"<section xmlns=\"http://xml.house.gov/schemas/uslm/1.0\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" style=\"-uslm-lc:I80\" id=\"ida483f2dc-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g\"><num value=\"280g\">§ 280g.</num><heading> Children’s asthma treatment grants program</heading><subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"ida483f2dd-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a\"><num value=\"a\" class=\"bold\">(a)</num><heading class=\"bold\"> Authority to make grants</heading><paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"ida483f2de-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/1\"><num value=\"1\" class=\"bold\">(1)</num><heading class=\"bold\"> In general</heading><chapeau style=\"-uslm-lc:I12\" class=\"indent1\">In addition to any other payments made under this chapter or title V of the Social Security Act [<ref href=\"/us/usc/t42/s701\">42 U.S.C. 701</ref> et seq.], the Secretary shall award grants to eligible entities to carry out the following purposes:</chapeau><subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida483f2df-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/1/A\"><num value=\"A\">(A)</num><content> To provide access to quality medical care for children who live in areas that have a high prevalence of asthma and who lack access to medical care.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida483f2e0-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/1/B\"><num value=\"B\">(B)</num><content> To provide on-site education to parents, children, health care providers, and medical teams to recognize the signs and symptoms of asthma, and to train them in the use of medications to treat asthma and prevent its exacerbations.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida483f2e1-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/1/C\"><num value=\"C\">(C)</num><content> To decrease preventable trips to the emergency room by making medication available to individuals who have not previously had access to treatment or education in the management of asthma.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida483f2e2-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/1/D\"><num value=\"D\">(D)</num><content> To provide other services, such as smoking cessation programs, home modification, and other direct and support services that ameliorate conditions that exacerbate or induce asthma.</content>\n</subparagraph>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"ida483f2e3-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/2\"><num value=\"2\" class=\"bold\">(2)</num><heading class=\"bold\"> <ref class=\"footnoteRef\" idref=\"fn002130\">1</ref><note type=\"footnote\" id=\"fn002130\"><num>1</num> So in original. Two pars. (2) have been enacted.</note> Certain projects</heading><chapeau style=\"-uslm-lc:I12\" class=\"indent1\">In making grants under paragraph (1), the Secretary may make grants designed to develop and expand the following projects:</chapeau><subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida483f2e4-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/2/A\"><num value=\"A\">(A)</num><content> Projects to provide comprehensive asthma services to children in accordance with the guidelines of the National Asthma Education and Prevention Program (through the National Heart, Lung and Blood Institute), including access to care and treatment for asthma in a community-based setting.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida48418f5-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/2/B\"><num value=\"B\">(B)</num><content> Projects to fully equip mobile health care clinics that provide preventive asthma care including diagnosis, physical examinations, pharmacological therapy, skin testing, peak flow meter testing, and other asthma-related health care services.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida48418f6-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/2/C\"><num value=\"C\">(C)</num><content> Projects to conduct validated asthma management education programs for patients with asthma and their families, including patient education regarding asthma management, family education on asthma management, and the distribution of materials, including displays and videos, to reinforce concepts presented by medical teams.</content>\n</subparagraph>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"ida48418f7-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/2\"><num value=\"2\" class=\"bold\">(2)</num><heading class=\"bold\"> <sup>1</sup> Award of grants</heading><subparagraph style=\"-uslm-lc:I18\" class=\"indent4 firstIndent-2\" id=\"ida48418f8-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/2/A\"><num value=\"A\" class=\"bold\">(A)</num><heading class=\"bold\"> Application</heading><clause style=\"-uslm-lc:I77\" class=\"indent5 firstIndent-2\" id=\"ida48418f9-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/2/A/i\"><num value=\"i\" class=\"bold\">(i)</num><heading class=\"bold\"> In general</heading><content><p style=\"-uslm-lc:I14\" class=\"indent3\">An eligible entity shall submit an application to the Secretary for a grant under this section in such form and manner as the Secretary may require.</p>\n</content>\n</clause>\n<clause style=\"-uslm-lc:I77\" class=\"indent5 firstIndent-2\" id=\"ida48418fa-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/2/A/ii\"><num value=\"ii\" class=\"bold\">(ii)</num><heading class=\"bold\"> Required information</heading><content><p style=\"-uslm-lc:I14\" class=\"indent3\">An application submitted under this subparagraph shall include a plan for the use of funds awarded under the grant and such other information as the Secretary may require.</p>\n</content>\n</clause>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I18\" class=\"indent4 firstIndent-2\" id=\"ida48418fb-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/2/B\"><num value=\"B\" class=\"bold\">(B)</num><heading class=\"bold\"> Requirement</heading><content><p style=\"-uslm-lc:I13\" class=\"indent2\">In awarding grants under this section, the Secretary shall give preference to eligible entities that demonstrate that the activities to be carried out under this section shall be in localities within areas of known or suspected high prevalence of childhood asthma or high asthma-related mortality or high rate of hospitalization or emergency room visits for asthma (relative to the average asthma prevalence rates and associated mortality rates in the United States). Acceptable data sets to demonstrate a high prevalence of childhood asthma or high asthma-related mortality may include data from Federal, State, or local vital statistics, claims data under title XIX or XXI of the Social Security Act [<ref href=\"/us/usc/t42/s1396\">42 U.S.C. 1396</ref> et seq., 1397aa et seq.], other public health statistics or surveys, or other data that the Secretary, in consultation with the Director of the Centers for Disease Control and Prevention, deems appropriate.</p>\n</content>\n</subparagraph>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"ida48418fc-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/a/3\"><num value=\"3\" class=\"bold\">(3)</num><heading class=\"bold\"> Definition of eligible entity</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">For purposes of this section, the term “eligible entity” means a public or nonprofit private entity (including a State or political subdivision of a State), or a consortium of any of such entities.</p>\n</content>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"ida484400d-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/b\"><num value=\"b\" class=\"bold\">(b)</num><heading class=\"bold\"> Coordination with other children’s programs</heading><chapeau style=\"-uslm-lc:I11\" class=\"indent0\">An eligible entity shall identify in the plan submitted as part of an application for a grant under this section how the entity will coordinate operations and activities under the grant with—</chapeau><paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida484400e-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/b/1\"><num value=\"1\">(1)</num><content> other programs operated in the State that serve children with asthma, including any such programs operated under title V, XIX, or XXI of the Social Security Act [<ref href=\"/us/usc/t42/s701\">42 U.S.C. 701</ref> et seq., 1396 et seq., 1397aa et seq.]; and</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida484400f-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/b/2\"><num value=\"2\">(2)</num><chapeau> one or more of the following—</chapeau><subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida4844010-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/b/2/A\"><num value=\"A\">(A)</num><content> the child welfare and foster care and adoption assistance programs under parts B and E of title IV of such Act [<ref href=\"/us/usc/t42/s620\">42 U.S.C. 620</ref> et seq., 670 et seq.];</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida4844011-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/b/2/B\"><num value=\"B\">(B)</num><content> the head start program established under the Head Start Act (<ref href=\"/us/usc/t42/s9831\">42 U.S.C. 9831</ref> et seq.);</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida4844012-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/b/2/C\"><num value=\"C\">(C)</num><content> the program of assistance under the special supplemental nutrition program for women, infants and children (WIC) under <ref href=\"/us/usc/t42/s1786\">section 1786 of this title</ref>;</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida4844013-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/b/2/D\"><num value=\"D\">(D)</num><content> local public and private elementary or secondary schools; or</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida4844014-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/b/2/E\"><num value=\"E\">(E)</num><content> public housing agencies, as defined in <ref href=\"/us/usc/t42/s1437a\">section 1437a of this title</ref>.</content>\n</subparagraph>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"ida4844015-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/c\"><num value=\"c\" class=\"bold\">(c)</num><heading class=\"bold\"> Evaluation</heading><chapeau style=\"-uslm-lc:I11\" class=\"indent0\">An eligible entity that receives a grant under this section shall submit to the Secretary an evaluation of the operations and activities carried out under the grant that includes—</chapeau><paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4844016-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/c/1\"><num value=\"1\">(1)</num><content> a description of the health status outcomes of children assisted under the grant;</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4844017-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/c/2\"><num value=\"2\">(2)</num><content> an assessment of the utilization of asthma-related health care services as a result of activities carried out under the grant;</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4844018-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/c/3\"><num value=\"3\">(3)</num><content> the collection, analysis, and reporting of asthma data according to guidelines prescribed by the Director of the Centers for Disease Control and Prevention; and</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4844019-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/c/4\"><num value=\"4\">(4)</num><content> such other information as the Secretary may require.</content>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"ida484401a-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d\"><num value=\"d\" class=\"bold\">(d)</num><heading class=\"bold\"> Preference for States that allow students to self-administer medication to treat asthma and anaphylaxis</heading><paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"ida484401b-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1\"><num value=\"1\" class=\"bold\">(1)</num><heading class=\"bold\"> Preference</heading><chapeau style=\"-uslm-lc:I12\" class=\"indent1\">The Secretary, in making any grant under this section or any other grant that is asthma-related (as determined by the Secretary) to a State, shall give preference to any State that satisfies the following:</chapeau><subparagraph style=\"-uslm-lc:I18\" class=\"indent4 firstIndent-2\" id=\"ida484401c-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/A\"><num value=\"A\" class=\"bold\">(A)</num><heading class=\"bold\"> In general</heading><chapeau style=\"-uslm-lc:I13\" class=\"indent2\">The State must require that each public elementary school and secondary school in that State will grant to any student in the school an authorization for the self-administration of medication to treat that student’s asthma or anaphylaxis, if—</chapeau><clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida484672d-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/A/i\"><num value=\"i\">(i)</num><content> a health care practitioner prescribed the medication for use by the student during school hours and instructed the student in the correct and responsible use of the medication;</content>\n</clause>\n<clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida484672e-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/A/ii\"><num value=\"ii\">(ii)</num><content> the student has demonstrated to the health care practitioner (or such practitioner’s designee) and the school nurse (if available) the skill level necessary to use the medication and any device that is necessary to administer such medication as prescribed;</content>\n</clause>\n<clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida484672f-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/A/iii\"><num value=\"iii\">(iii)</num><content> the health care practitioner formulates a written treatment plan for managing asthma or anaphylaxis episodes of the student and for medication use by the student during school hours; and</content>\n</clause>\n<clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida4846730-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/A/iv\"><num value=\"iv\">(iv)</num><content> the student’s parent or guardian has completed and submitted to the school any written documentation required by the school, including the treatment plan formulated under clause (iii) and other documents related to liability.</content>\n</clause>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I18\" class=\"indent4 firstIndent-2\" id=\"ida4846731-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/B\"><num value=\"B\" class=\"bold\">(B)</num><heading class=\"bold\"> Scope</heading><chapeau style=\"-uslm-lc:I13\" class=\"indent2\">An authorization granted under subparagraph (A) must allow the student involved to possess and use his or her medication—</chapeau><clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida4846732-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/B/i\"><num value=\"i\">(i)</num><content> while in school;</content>\n</clause>\n<clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida4846733-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/B/ii\"><num value=\"ii\">(ii)</num><content> while at a school-sponsored activity, such as a sporting event; and</content>\n</clause>\n<clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida4846734-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/B/iii\"><num value=\"iii\">(iii)</num><content> in transit to or from school or school-sponsored activities.</content>\n</clause>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I18\" class=\"indent4 firstIndent-2\" id=\"ida4846735-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/C\"><num value=\"C\" class=\"bold\">(C)</num><heading class=\"bold\"> Duration of authorization</heading><chapeau style=\"-uslm-lc:I13\" class=\"indent2\">An authorization granted under subparagraph (A)—</chapeau><clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida4846736-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/C/i\"><num value=\"i\">(i)</num><content> must be effective only for the same school and school year for which it is granted; and</content>\n</clause>\n<clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida4846737-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/C/ii\"><num value=\"ii\">(ii)</num><content> must be renewed by the parent or guardian each subsequent school year in accordance with this subsection.</content>\n</clause>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I18\" class=\"indent4 firstIndent-2\" id=\"ida4846738-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/D\"><num value=\"D\" class=\"bold\">(D)</num><heading class=\"bold\"> Backup medication</heading><content><p style=\"-uslm-lc:I13\" class=\"indent2\">The State must require that backup medication, if provided by a student’s parent or guardian, be kept at a student’s school in a location to which the student has immediate access in the event of an asthma or anaphylaxis emergency.</p>\n</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I18\" class=\"indent4 firstIndent-2\" id=\"ida4846739-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/E\"><num value=\"E\" class=\"bold\">(E)</num><heading class=\"bold\"> Maintenance of information</heading><content><p style=\"-uslm-lc:I13\" class=\"indent2\">The State must require that information described in subparagraphs (A)(iii) and (A)(iv) be kept on file at the student’s school in a location easily accessible in the event of an asthma or anaphylaxis emergency.</p>\n</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I18\" class=\"indent4 firstIndent-2\" id=\"ida484673a-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/F\"><num value=\"F\" class=\"bold\">(F)</num><heading class=\"bold\"> School personnel administration of epinephrine</heading><chapeau style=\"-uslm-lc:I13\" class=\"indent2\">In determining the preference (if any) to be given to a State under this subsection, the Secretary shall give additional preference to a State that provides to the Secretary the certification described in subparagraph (G) and that requires that each public elementary school and secondary school in the State—</chapeau><clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida4848e4b-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/F/i\"><num value=\"i\">(i)</num><content> permits trained personnel of the school to administer epinephrine to any student of the school reasonably believed to be having an anaphylactic reaction;</content>\n</clause>\n<clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida4848e4c-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/F/ii\"><num value=\"ii\">(ii)</num><content> maintains a supply of epinephrine in a secure location that is easily accessible to trained personnel of the school for the purpose of administration to any student of the school reasonably believed to be having an anaphylactic reaction; and</content>\n</clause>\n<clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida4848e4d-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/F/iii\"><num value=\"iii\">(iii)</num><content> has in place a plan for having on the premises of the school during all operating hours of the school one or more individuals who are trained personnel of the school.</content>\n</clause>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I18\" class=\"indent4 firstIndent-2\" id=\"ida4848e4e-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/1/G\"><num value=\"G\" class=\"bold\">(G)</num><heading class=\"bold\"> Civil liability protection law</heading><content><p style=\"-uslm-lc:I13\" class=\"indent2\">The certification required in subparagraph (F) shall be a certification made by the State attorney general that the State has reviewed any applicable civil liability protection law to determine the application of such law with regard to elementary and secondary school trained personnel who may administer epinephrine to a student reasonably believed to be having an anaphylactic reaction and has concluded that such law provides adequate civil liability protection applicable to such trained personnel. For purposes of the previous sentence, the term “civil liability protection law” means a State law offering legal protection to individuals who give aid on a voluntary basis in an emergency to an individual who is ill, in peril, or otherwise incapacitated.</p>\n</content>\n</subparagraph>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"ida4848e4f-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/2\"><num value=\"2\" class=\"bold\">(2)</num><heading class=\"bold\"> Rule of construction</heading><content><p style=\"-uslm-lc:I12\" class=\"indent1\">Nothing in this subsection creates a cause of action or in any other way increases or diminishes the liability of any person under any other law.</p>\n</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I79\" class=\"indent3 firstIndent-2\" id=\"ida4848e50-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/3\"><num value=\"3\" class=\"bold\">(3)</num><heading class=\"bold\"> Definitions</heading><chapeau style=\"-uslm-lc:I12\" class=\"indent1\">For purposes of this subsection:</chapeau><subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida4848e51-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/3/A\"><num value=\"A\">(A)</num><content> The terms “elementary school” and “secondary school” have the meaning given to those terms in <ref href=\"/us/usc/t20/s7801\">section 7801 of title 20</ref>.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida4848e52-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/3/B\"><num value=\"B\">(B)</num><content> The term “health care practitioner” means a person authorized under law to prescribe drugs subject to <ref href=\"/us/usc/t21/s353/b\">section 353(b) of title 21</ref>.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida4848e53-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/3/C\"><num value=\"C\">(C)</num><content> The term “medication” means a drug as that term is defined in <ref href=\"/us/usc/t21/s321\">section 321 of title 21</ref> and includes inhaled bronchodilators and auto-injectable epinephrine.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida4848e54-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/3/D\"><num value=\"D\">(D)</num><content> The term “self-administration” means a student’s discretionary use of his or her prescribed asthma or anaphylaxis medication, pursuant to a prescription or written direction from a health care practitioner.</content>\n</subparagraph>\n<subparagraph style=\"-uslm-lc:I13\" class=\"indent2\" id=\"ida484b565-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/3/E\"><num value=\"E\">(E)</num><chapeau> The term “trained personnel” means, with respect to an elementary or secondary school, an individual—</chapeau><clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida484b566-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/3/E/i\"><num value=\"i\">(i)</num><content> who has been designated by the principal (or other appropriate administrative staff) of the school to administer epinephrine on a voluntary basis outside their scope of employment;</content>\n</clause>\n<clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida484b567-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/3/E/ii\"><num value=\"ii\">(ii)</num><content> who has received training in the administration of epinephrine; and</content>\n</clause>\n<clause style=\"-uslm-lc:I14\" class=\"indent3\" id=\"ida484b568-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/d/3/E/iii\"><num value=\"iii\">(iii)</num><content> whose training in the administration of epinephrine meets appropriate medical standards and has been documented by appropriate administrative staff of the school.</content>\n</clause>\n</subparagraph>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"ida484b569-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s280g/e\"><num value=\"e\" class=\"bold\">(e)</num><heading class=\"bold\"> Authorization of appropriations</heading><content><p style=\"-uslm-lc:I11\" class=\"indent0\">For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2001 through 2005.</p>\n</content>\n</subsection>\n<sourceCredit id=\"ida484b56a-09a0-11eb-a85b-f5cef3d06f4d\">(<ref href=\"/us/act/1944-07-01/ch373\">July 1, 1944, ch. 373</ref>, title III, § 399L, as added <ref href=\"/us/pl/106/310/dA/tV/s501\">Pub. L. 106–310, div. A, title V, § 501</ref>, <date date=\"2000-10-17\">Oct. 17, 2000</date>, <ref href=\"/us/stat/114/1113\">114 Stat. 1113</ref>; amended <ref href=\"/us/pl/108/377/s3/a\">Pub. L. 108–377, § 3(a)</ref>, <date date=\"2004-10-30\">Oct. 30, 2004</date>, <ref href=\"/us/stat/118/2203\">118 Stat. 2203</ref>; <ref href=\"/us/pl/113/48/s2\">Pub. L. 113–48, § 2</ref>, <date date=\"2013-11-13\">Nov. 13, 2013</date>, <ref href=\"/us/stat/127/575\">127 Stat. 575</ref>; <ref href=\"/us/pl/114/95/tIX/s9215/kkk/2\">Pub. L. 114–95, title IX, § 9215(kkk)(2)</ref>, <date date=\"2015-12-10\">Dec. 10, 2015</date>, <ref href=\"/us/stat/129/2187\">129 Stat. 2187</ref>.)</sourceCredit>\n<notes type=\"uscNote\" id=\"ida484b56b-09a0-11eb-a85b-f5cef3d06f4d\">\n<note style=\"-uslm-lc:I75\" topic=\"referencesInText\" id=\"ida484b56c-09a0-11eb-a85b-f5cef3d06f4d\">\n<heading class=\"centered smallCaps\">References in Text</heading><p style=\"-uslm-lc:I21\" class=\"indent0\">The Social Security Act, referred to in subsecs. (a)(1), (2)(B) and (b)(1), (2)(A), is <ref href=\"/us/act/1935-08-14/ch531\">act Aug. 14, 1935, ch. 531</ref>, <ref href=\"/us/stat/49/620\">49 Stat. 620</ref>, as amended. Parts B and E of title IV of the Act are classified generally to parts B (§ 620 et seq.) and E (§ 670 et seq.), respectively, of subchapter IV of chapter 7 of this title. Titles V, XIX, and XXI of the Act are classified generally to subchapters V (§ 701 et seq.), XIX (§ 1396 et seq.), and XXI (§ 1397aa et seq.), respectively, of chapter 7 of this title. For complete classification of this Act to the Code, see <ref href=\"/us/usc/t42/s1305\">section 1305 of this title</ref> and Tables.</p>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">The Head Start Act, referred to in subsec. (b)(2)(B), is subchapter B (§§ 635–657) of chapter 8 of subtitle A of title VI of <ref href=\"/us/pl/97/35\">Pub. L. 97–35</ref>, <date date=\"1981-08-13\">Aug. 13, 1981</date>, <ref href=\"/us/stat/95/499\">95 Stat. 499</ref>, as amended, which is classified generally to subchapter II (§ 9831 et seq.) of chapter 105 of this title. For complete classification of this Act to the Code, see Short Title note set out under <ref href=\"/us/usc/t42/s9801\">section 9801 of this title</ref> and Tables.</p>\n</note>\n<note style=\"-uslm-lc:I74\" topic=\"priorProvisions\" id=\"ida484b56d-09a0-11eb-a85b-f5cef3d06f4d\"><heading class=\"centered smallCaps\">Prior Provisions</heading><p style=\"-uslm-lc:I21\" class=\"indent0\">A prior section 399L of act <date date=\"1944-07-01\">July 1, 1944</date>, was renumbered section 399F and is classified to <ref href=\"/us/usc/t42/s280e–4\">section 280e–4 of this title</ref>.</p>\n</note>\n<note style=\"-uslm-lc:I74\" topic=\"amendments\" id=\"ida484b56e-09a0-11eb-a85b-f5cef3d06f4d\"><heading class=\"centered smallCaps\">Amendments</heading><p style=\"-uslm-lc:I21\" class=\"indent0\">2015—Subsec. (d)(3)(A). <ref href=\"/us/pl/114/95\">Pub. L. 114–95</ref> made technical amendment to reference in original act which appears in text as reference to <ref href=\"/us/usc/t20/s7801\">section 7801 of title 20</ref>.</p>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">2013—Subsec. (d)(1)(F), (G). <ref href=\"/us/pl/113/48/s2/1\">Pub. L. 113–48, § 2(1)</ref>, added subpars. (F) and (G).</p>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">Subsec. (d)(3)(E). <ref href=\"/us/pl/113/48/s2/2\">Pub. L. 113–48, § 2(2)</ref>, added subpar. (E).</p>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">2004—Subsecs. (d), (e). <ref href=\"/us/pl/108/377\">Pub. L. 108–377</ref> added subsec. (d) and redesignated former subsec. (d) as (e).</p>\n</note>\n<note style=\"-uslm-lc:I74\" topic=\"effectiveDateOfAmendment\" id=\"ida484dc7f-09a0-11eb-a85b-f5cef3d06f4d\"><heading class=\"centered smallCaps\">Effective Date of 2015 Amendment</heading><p style=\"-uslm-lc:I21\" class=\"indent0\">Amendment by <ref href=\"/us/pl/114/95\">Pub. L. 114–95</ref> effective <date date=\"2015-12-10\">Dec. 10, 2015</date>, except with respect to certain noncompetitive programs and competitive programs, see <ref href=\"/us/pl/114/95/s5\">section 5 of Pub. L. 114–95</ref>, set out as a note under <ref href=\"/us/usc/t20/s6301\">section 6301 of Title 20</ref>, Education.</p>\n</note>\n<note style=\"-uslm-lc:I74\" topic=\"effectiveDateOfAmendment\" id=\"ida484dc80-09a0-11eb-a85b-f5cef3d06f4d\"><heading class=\"centered smallCaps\">Effective Date of 2004 Amendment</heading><p><ref href=\"/us/pl/108/377/s3/b\">Pub. L. 108–377, § 3(b)</ref>, <date date=\"2004-10-30\">Oct. 30, 2004</date>, <ref href=\"/us/stat/118/2204\">118 Stat. 2204</ref>, provided that: <quotedContent origin=\"/us/pl/108/377/s3/b\">“The amendments made by this section [amending this section] shall apply only with respect to grants made on or after the date that is 9 months after the date of the enactment of this Act [<date date=\"2004-10-30\">Oct. 30, 2004</date>].”</quotedContent>\n</p>\n</note>\n<note style=\"-uslm-lc:I74\" topic=\"miscellaneous\" id=\"ida484dc81-09a0-11eb-a85b-f5cef3d06f4d\"><heading class=\"centered smallCaps\">Findings of 2004 Amendment</heading><p><ref href=\"/us/pl/108/377/s2\">Pub. L. 108–377, § 2</ref>, <date date=\"2004-10-30\">Oct. 30, 2004</date>, <ref href=\"/us/stat/118/2202\">118 Stat. 2202</ref>, provided that: <quotedContent origin=\"/us/pl/108/377/s2\">\n<inline>“The Congress finds the following:</inline>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"1\">“(1)</num><content> Asthma is a chronic condition requiring lifetime, ongoing medical intervention.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"2\">“(2)</num><content> In 1980, 6,700,000 Americans had asthma.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"3\">“(3)</num><content> In 2001, 20,300,000 Americans had asthma; 6,300,000 children under age 18 had asthma.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"4\">“(4)</num><content> The prevalence of asthma among African-American children was 40 percent greater than among Caucasian children, and more than 26 percent of all asthma deaths are in the African-American population.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"5\">“(5)</num><content> In 2000, there were 1,800,000 asthma-related visits to emergency departments (more than 728,000 of these involved children under 18 years of age).</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"6\">“(6)</num><content> In 2000, there were 465,000 asthma-related hospitalizations (214,000 of these involved children under 18 years of age).</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"7\">“(7)</num><content> In 2000, 4,487 people died from asthma, and of these 223 were children.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"8\">“(8)</num><content> According to the Centers for Disease Control and Prevention, asthma is a common cause of missed school days, accounting for approximately 14,000,000 missed school days annually.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"9\">“(9)</num><content> According to the New England Journal of Medicine, working parents of children with asthma lose an estimated $1,000,000,000 a year in productivity.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"10\">“(10)</num><content> At least 30 States have legislation protecting the rights of children to carry and self-administer asthma metered-dose inhalers, and at least 18 States expand this protection to epinephrine auto-injectors.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"11\">“(11)</num><content> Tragic refusals of schools to permit students to carry their inhalers and auto-injectable epinephrine have occurred, some resulting in death and spawning litigation.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"12\">“(12)</num><content> School district medication policies must be developed with the safety of all students in mind. The immediate and correct use of asthma inhalers and auto-injectable epinephrine are necessary to avoid serious respiratory complications and improve health care outcomes.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"13\">“(13)</num><content> No school should interfere with the patient-physician relationship.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"14\">“(14)</num><content> Anaphylaxis, or anaphylactic shock, is a systemic allergic reaction that can kill within minutes. Anaphylaxis occurs in some asthma patients. According to the American Academy of Allergy, Asthma, and Immunology, people who have experienced symptoms of anaphylaxis previously are at risk for subsequent reactions and should carry an epinephrine auto-injector with them at all times, if prescribed.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I22\" class=\"indent1\"><num value=\"15\">“(15)</num><content> An increasing number of students and school staff have life-threatening allergies. Exposure to the affecting allergen can trigger anaphylaxis. Anaphylaxis requires prompt medical intervention with an injection of epinephrine.”</content>\n</paragraph>\n</quotedContent>\n</p>\n</note>\n</notes>\n</section>","provision":null,"duplicates":[],"release":{"label":"116-252","currency_date":"2020-12-22","congress":116,"law_num":252,"excluded_laws":[],"update_num":null,"seq":222,"is_partial":false,"caveat":null,"titles_affected":["18","20","31","34","40","42"],"ingested_titles":[]},"served_from":{"label":"116-252","currency_date":"2020-12-22","congress":116,"law_num":252,"excluded_laws":[],"update_num":null,"seq":222,"is_partial":false,"caveat":null,"titles_affected":["18","20","31","34","40","42"],"ingested_titles":[]},"content_first_seen":{"label":"116-163","currency_date":"2020-10-02","congress":116,"law_num":163,"excluded_laws":[],"update_num":null,"seq":214,"is_partial":false,"caveat":null,"titles_affected":["01","02","03","06","07","08","10","15","17","18","21","22","23","26","28","31","35","36","38","40","42","45","49","50"],"ingested_titles":[]},"is_exact":true,"note":null}